Goodpasture Syndrome in Dialysis-Dependent Kidney Failure with Global Glomerulosclerosis or Crescents on Biopsy
This protocol addresses a specific subset of Goodpasture syndrome: patients who are already dialysis-dependent at presentation and whose kidney biopsy shows particularly severe glomerular damage — without accompanying pulmonary haemorrhage.
Defining Clinical Criteria
All three of the following must be present:
- Dialysis dependence at the time of presentation
- Kidney biopsy showing either 100% glomerular crescents or more than 50% global glomerulosclerosis on an adequate sample
- Absence of pulmonary haemorrhage
This combination of findings — dialysis dependence, severe biopsy changes, and no pulmonary involvement — defines an important exception within anti-GBM disease management. Guidelines specifically distinguish this subgroup from the broader anti-GBM population, with distinct implications for how treatment is approached. The full protocol details the recommended course of action.
References
DOI: 10.55563/clinexprheumatol/tep3k5
These guidelines recommend initiating immunosuppression with cyclophosphamide and corticosteroids plus plasmapheresis in all patients with anti-GBM glomerulonephritis, except in those who are treated with dialysis at presentation, have 100% crescents or more than 50% global glomerulosclerosis in an adequate biopsy sample, and do not have pulmonary haemorrhage.
View source ↗